The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

Share Price Information for WHIreland (WHI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.25
Bid: 4.00
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.50 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.25
WHI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Debt Capital Markets Business

10 May 2022 07:00

RNS Number : 8342K
W.H. Ireland Group PLC
10 May 2022
 

 

 

10 May 2022

 

RNS Reach

 

WH Ireland Group Plc

 

("WH Ireland", the "Group" or the "Company")

 

New Debt Capital Markets business

Creating a full service offering across the debt and equity markets

WH Ireland (AIM: WHI) is pleased to announce the establishment of a new Debt Capital Markets ("DCM") business to complement the Group's existing Equity Capital Markets and Private Growth Capital businesses. This creates a full service Capital Markets offering, enabling our clients to undertake a variety of strategic fundraising options to ensure the best possible outcome for their businesses.

The DCM business has been established following a number of senior appointments, as follows:

· Stuart Galvin - Managing Director and Head of Debt Products Group

· Scott Beattie - Managing Director and Head of DCM

· David Kent - Managing Director, DCM

· Patrick King - Managing Director and Head of Fixed Income Sales

· Mark Truman - Managing Director and Head of Debt Trading

Collectively, the team averages over 30 years of experience in disciplines such as corporate finance, fixed income, equity and convertible products and alternative assets across the UK, European and Asian capital markets, with previous experience at financial institutions including Peel Hunt, Oppenheimer, Robert Fleming & Co, Deloitte, Herbert Smith, Equiniti, Williams de Broe, BNP Paribas, Prudential Bache, Merrill Lynch, Jefferies International and JP Morgan.

WH Ireland recently completed its first DCM transaction, as joint lead manager to EnQuest PLC following the launch of its sterling denominated 9% guaranteed retail eligible notes, which successfully raised £133m, as announced on 21 April 2022.

Commenting on today's announcement, Phillip Wale, CEO of WH Ireland, said:

"On behalf of the Company, I am delighted to welcome Stuart, Scott, David, Patrick and Mark to WH Ireland. Together, these new hires bring a significant wealth of knowledge and expertise across debt capital markets, with a proven track record of origination and execution.

"This new DCM capability ensures that WH Ireland's successful Capital Markets division can provide a full service equity and debt offering to support the various fundraising and advisory needs of our broad and growing client base."

Stuart Galvin, Managing Director and Head of Debt Products Group, said:

"We are all delighted to be joining WH Ireland at this exciting time and to have delivered our first successful transaction for the firm. We look forward to helping Phillip and the team continue to build out a broader Capital Markets business".

 

 

Biographies of new appointees

Stuart has over 30 years of experience in fixed income, equity and equity-linked products at major banks across the UK, European and Asian markets, including Peel Hunt, Cenkos, Canaccord and JP Morgan.

Scott is a seasoned finance professional, with more than 30 years of experience in originating and executing transactions, having previously worked for Peel Hunt, Oppenheimer and Robert Fleming & Co.

David is a senior capital markets and corporate finance professional with over 25 years of experience in executing transactions across multiple markets and capital structures, and has previously had roles with Peel Hunt, Oppenheimer, Deloitte and Herbert Smith.

Patrick has more than 30 years of experience in fixed income, equity and convertible products in Europe, and has previously worked for Peel Hunt, Equiniti, Williams de Broe, BNP Paribas and Prudential Bache.

Mark has over 30 years of experience covering equities, fixed Income and alternative assets, and has previously had roles at Merrill Lynch, Jefferies International and WMG Advisors.

 

For further information please contact:

WH Ireland Group plc

www.whirelandplc.com

Phillip Wale, Chief Executive Officer

+44(0) 20 7220 1666

Canaccord Genuity Limited

www.canaccordgenuity.com

Andrew Potts / Tom Diehl 

+44(0) 20 7523 8000

MHP Communications

whireland@mhpc.com

Reg Hoare / James Bavister

+44 (0) 20 3128 8793

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUKOVRUVUVRAR
Date   Source Headline
27th Dec 20237:00 amRNSInterim Results for Six Months ended 30 Sep 2023
16th Nov 20237:00 amRNSBoard Changes
24th Oct 20232:07 pmRNSResult of AGM
27th Sep 20237:00 amRNSFinal Results and Notice of AGM
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 202310:08 amRNSHolding(s) in Company
22nd Aug 202310:07 amRNSHolding(s) in Company
21st Aug 20239:26 amRNSHolding(s) in Company
18th Aug 202311:06 amRNSHolding(s) in Company
17th Aug 20235:14 pmRNSHolding(s) in Company
17th Aug 20234:09 pmRNSHolding(s) in Company
17th Aug 20239:16 amRNSHolding(s) in Company
16th Aug 20232:56 pmRNSHolding(s) in Company
15th Aug 20232:59 pmRNSResult of General Meeting and Total Voting Rights
31st Jul 20237:25 amRNSPosting of Circular and Notice of General Meeting
28th Jul 20238:53 amRNSResult of Placing
28th Jul 20237:00 amRNSTrading Update & Proposed Placing
22nd Jun 20239:05 amRNSESOT Purchases
15th Jun 20234:57 pmRNSESOT Purchases
24th Apr 20232:11 pmRNSESOT Purchases
21st Apr 20239:20 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSIssue of Equity
3rd Apr 20237:00 amRNSYear End Trading Update
14th Mar 202311:39 amRNSESOT Purchases
9th Feb 20239:10 amRNSESOT Trading
25th Jan 20238:47 amRNSTotal Voting Rights
17th Jan 20238:44 amRNSESOT Purchases
11th Jan 202310:45 amRNSIssue of Equity - Total Voting Rights
20th Dec 20222:08 pmRNSTR-1: Notification of major holdings
16th Dec 202210:19 amRNSRecent appointments across the Group
16th Dec 20227:00 amRNSInterim Results
7th Dec 20227:00 amRNSESOT Purchases
7th Nov 20225:00 pmRNSESOT Trading
4th Nov 20223:45 pmRNSESOT Trading
4th Oct 20228:18 amRNSESOT Purchases
8th Sep 20224:10 pmRNSResult of AGM
8th Sep 20228:23 amRNSESOT Purchases
5th Aug 20227:00 amRNSESOT Purchases
1st Aug 202210:18 amRNSPDMR Shareholding
27th Jul 20227:00 amRNSFinal Results and Notice of AGM
19th Jul 20227:00 amRNSConfirmation of Chairman Appointment
12th Jul 20227:00 amRNSESOT Purchases
20th Jun 20227:00 amRNSESOT Purchases
10th May 20227:00 amRNSNew Debt Capital Markets Business
6th May 20227:37 amRNSESOT Purchases
27th Apr 20224:05 pmRNSIssue of Options
12th Apr 20228:51 amRNSESOT Purchases
31st Mar 20227:00 amRNSBoard Changes
9th Mar 20227:00 amRNSESOT Purchases
17th Feb 202211:23 amRNSPDMR Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.